Why Melasma Keeps Coming Back: Managing Stubborn Pigmentation in Singapore

Melasma has a particular way of disappointing people. A course of treatment fades it convincingly, sometimes almost completely, and then — months later, often after a holiday, a pregnancy, or simply a sunny season — it returns in the same symmetrical pattern across the cheeks, forehead or upper lip. The natural conclusion is that the treatment failed. More often, the treatment worked exactly as it should have, and the underlying condition was never actually cured, only quieted.

Melasma is a chronic acquired hypermelanosis — a long-term pigmentation disorder, not a single blemish — that affects mainly women during their reproductive years and is more common and more visible in the skin types typical of Singapore and the wider region. Treating it as a stain to be removed, rather than a condition to be managed, is the most common source of frustration.

A recurring condition, not a stain

Pigmentation research over the past decade has moved well beyond the idea that melasma is simply overactive melanocytes producing too much pigment. The current understanding involves a more layered process: disrupted basement membrane, increased blood vessel density in the affected skin, and signalling between sun-damaged keratinocytes and pigment-producing cells that keeps the cycle active long after any single treatment session ends.

This matters clinically because it explains recurrence without needing to invoke treatment failure. The pigment-producing machinery in melasma-affected skin remains primed to reactivate whenever its usual triggers reappear — which is a very different problem from a one-off patch of sun damage that, once treated, does not come back.

The triggers that matter more than people expect

• Ultraviolet exposure, including the incidental daily kind — through a car window, walking between buildings, or sitting near a bright window indoors
• Visible light, particularly blue light, which has been shown to trigger pigmentation in melasma-prone skin even without meaningful UV exposure
• Hormonal shifts — pregnancy, hormonal contraception, and hormone replacement therapy are the most consistently documented drivers
• Heat and inflammation, including from aggressive facials, over-exfoliation, or procedures performed too intensely for melasma-prone skin

In a climate with consistently high year-round UV and equatorial daylight hours, the first two triggers are rarely occasional. This is one reason melasma management in Singapore leans more heavily on relentless, unglamorous sun protection than it does in more temperate climates — the trigger is present essentially every day, not for a few months a year.

Melasma is not treated once. It is managed continuously, in the same way a chronic condition is managed rather than cured.

Why barrier health and restraint matter here

One of the more counterproductive patterns in melasma treatment is over-treatment: aggressive peels or high-fluence laser settings applied in pursuit of faster clearance, which instead inflame the skin and trigger post-inflammatory pigmentation on top of the melasma already present. A compromised barrier is more reactive, and reactive skin is more likely to pigment in response to any subsequent irritation — the same barrier-first framework that governs skin health generally applies with particular force here.

Melasma also does not respond quickly. Tyrosinase-inhibiting topical agents typically need eight to twelve weeks of consistent use before their effect can be fairly judged, which is longer than most people expect and is exactly the kind of timeline mismatch addressed by evaluating skincare on the skin's own clock rather than the market's.

A tiered approach

• Daily broad-spectrum sun protection with a tinted component, since untinted sunscreens filter UV but not the visible light that also triggers melasma
• Topical agents — most commonly hydroquinone, azelaic acid, tranexamic acid, and niacinamide, used in combination or in rotation rather than any single ingredient alone
• Oral tranexamic acid, for selected patients without contraindications, as an adjunct to topical treatment rather than a replacement for it
• Procedural adjuncts such as low-fluence laser or gentle chemical peels, used cautiously and only alongside — never instead of — trigger control, since overly aggressive procedures carry a real risk of rebound pigmentation

What a considered consultation assesses

• Depth of pigmentation — epidermal, dermal, or mixed — since this materially affects which treatments are likely to help
• A realistic trigger history: sun and heat exposure pattern, hormonal history, and prior treatments tried
• Response to any previous treatment, which is often a more reliable guide than the diagnosis alone
• An honest timeline: control within a few months is a reasonable goal; permanent elimination is not

The pigment left behind by inflammation follows a similar pathway to melasma itself, which is why the post-inflammatory marks that sometimes follow adult acne and its scarring are assessed with much of the same trigger-control logic, even though the initial cause is entirely different.